[go: up one dir, main page]

HK1169025A - Methods for treating type 2 diabetes in patients resistant to previous treatment with other anti-diabetic drugs employing an sglt2 inhibitor and compositions thereof - Google Patents

Methods for treating type 2 diabetes in patients resistant to previous treatment with other anti-diabetic drugs employing an sglt2 inhibitor and compositions thereof Download PDF

Info

Publication number
HK1169025A
HK1169025A HK12109709.9A HK12109709A HK1169025A HK 1169025 A HK1169025 A HK 1169025A HK 12109709 A HK12109709 A HK 12109709A HK 1169025 A HK1169025 A HK 1169025A
Authority
HK
Hong Kong
Prior art keywords
diabetes
compositions
methods
previous treatment
treating type
Prior art date
Application number
HK12109709.9A
Other languages
Chinese (zh)
Inventor
Paul Strumph
Stephanie Moran
James List
Original Assignee
Astrazeneca Uk Limited
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Uk Limited, Astrazeneca Ab filed Critical Astrazeneca Uk Limited
Publication of HK1169025A publication Critical patent/HK1169025A/en

Links

HK12109709.9A 2009-05-27 2010-05-26 Methods for treating type 2 diabetes in patients resistant to previous treatment with other anti-diabetic drugs employing an sglt2 inhibitor and compositions thereof HK1169025A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61/181,442 2009-05-27

Publications (1)

Publication Number Publication Date
HK1169025A true HK1169025A (en) 2013-01-18

Family

ID=

Similar Documents

Publication Publication Date Title
PH12018500767A1 (en) Pharmaceutical composition, methods for treating and uses thereof
TN2011000416A1 (en) Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
ZA200902084B (en) Combination therapy with SGLT-2 inhibitors and their pharmaceutical compositions
EP2217596B8 (en) Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119
EG25189A (en) Improvements in and relating to drive mechanisms suitable for use in drug delivery devices.
WO2008106102A9 (en) Inhibitors of rtp801 and their use in disease treatment
WO2011069141A3 (en) Interferon therapies in combination with blockade of stat3 activation
IL207546A0 (en) Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases
IL206080A0 (en) Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases
EP2070540A4 (en) Drug composition for treating 2 type diabetes and its chronicity neopathy
ZA200905970B (en) Pharmaceutical composition for treatment of diabetic complications
EP2244690A4 (en) Methods and compositions for treating dermatological diseases and conditions
IL198723A0 (en) Methods and compositions for therapeutic treatment
IL208463A (en) 2-heterocyclyl-fused pyrrole compounds, pharmaceutical compositions comprising them and their use in the prophylaxis or treatment of diabetes or obesity
EP2322175A4 (en) Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof
TNSN08506A1 (en) Substituted carboxamides
PL2308497T3 (en) Pharmaceutical composition with glycosaminoglycans and use thereof in the treatment of chronic ulcers
PL2645878T3 (en) Prevention or treatment of overweight and obesity in type 2 diabetic patients
WO2007080149A8 (en) Treatment of stressed patients
EP2329820A4 (en) Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof
IL218069A (en) Oligosaccharide compound, a medicament and a pharmaceutical composition comprising it and the compound for use in medical treatment
HK1169025A (en) Methods for treating type 2 diabetes in patients resistant to previous treatment with other anti-diabetic drugs employing an sglt2 inhibitor and compositions thereof
GB0601950D0 (en) Compositions and methods of treating diabetes
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
PL2243478T3 (en) Pharmaceutical composition combining an antiarthritic agent and an interleukin-1 inhibiting agent, which can be used to control and treat osteoarthritis and related diseases